Fundraising FoxTVM Capital
Venture capitalMunich · Seed–Late Stage · 10 people tracked
Also known as TVM CAPITAL GMBH · TVM Techno Venture Management GmbH
Find your way into TVM Capital
Sign up to see every warm intro you have to TVM Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the TVM Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
TVM Capital Life Science pursues a two-pronged investment strategy. First, it finances innovative early-stage therapeutics using a single-asset company approach, leveraging a strategic relationship with Eli Lilly and Company. Second, it invests in differentiated commercial-stage medtech, diagnostics, and digital health products, as well as late-stage therapeutics. The firm aims to develop and market products with the potential to transform medical practice and improve outcomes for patients and the healthcare system, while building value for its investors. It emphasizes strong support for its portfolio companies.
Source: firm website, verified Aug 3, 2026.
Team · 10 people
from the firm's website & curated & public directories
Founder mafia
2 people who came through TVM Capital went on to found or lead other companies.
What they invest in
from 6 of 9 portfolio companiesHealthtech ×4Medical Devices ×4Biotech ×3AI & Machine Learning ×1Digital Health ×1Hardware ×1New Materials ×1
HQs:United States×6
Investments · 9 tracked
founders shown can be your intro pathBy year:2024 · 12021 · 12017 · 12015 · 14 dated
Access Vascular develops thrombus-evading intravascular catheters made from a proprietary biomaterial, offering an FDA-cleared PICC and the HydroMID peripherally inserted midline catheter to reduce vascular access complications.
BiotechHealthtechMedical DevicesNew MaterialsBedford, US
James Biggins(Chief Executive Officer, President and Founder)inDennis Byrne(Chief Commercial Officer)inScott Blood(VP of Regulatory and Quality)inKatie Motherway(VP of Human Resources)inPaul Sabin(Director)Joseph Pellegrino(Director)
Board seatLuc Marengère· per SEC Form D
Co-investorsTVM Capital Life ScienceGreen Park & Golf Ventures
Vektor Medical develops patient-specific computational models of cardiac electrophysiology to support the diagnosis and treatment of heart arrhythmias.
AI & Machine LearningDigital HealthHealthtechMedical DevicesCarlsbad, US
Chris Villongco(Head of Technology / CTO)inRob Krummen(CEO (formerly President & COO))inKelly Perez(Head of Finance)inAlexander Michael Monko(Executive Officer, Director)
Board seatLuc Marengère· per SEC Form D · $37.5M raise · filed Feb 2024
Co-investorsSolas BioVenturesTVM Capital Life Science
RejuvenAir, developed by CSA Medical, is a bronchoscopic cryosurgical device that sprays metered doses of liquid nitrogen to destroy damaged airway cells and treat the underlying cause of COPD with Chronic Bronchitis.
HealthtechMedical DevicesLutherville, US
Ellen Sheets(Executive Officer, Director)inIan J. Vawter(Executive Officer)Steven Schaefer(Executive Officer)inWilliam Floyd(Executive Officer, Director)inVincent Owens(Director)Richard Kent(Director)
Co-investorsAscension VenturesFirst AnalysisNew Markets Venture PartnersSV Health InvestorsBlue Heron CapitalTVM Capital Life Science
Egg Medical develops the EggNest, a scatter radiation shielding system designed to reduce radiation exposure for interventional fluoroscopy teams during cardiac catheterization and endovascular procedures.
HardwareHealthtechMedical DevicesArden Hills, US
Robert F. Wilson(Founder & Chief Executive Officer)inJohn Gainor(Co-founder & Chief Technology Officer)inScott Youngstrom(Chief Financial Officer)inGavin Philipps(Chief Commercial Officer)in
BoardMarc Riviere(Director)Luc Marengere(Director)
Co-investorsJStar Capital InvestmentsTVM Capital Life Science
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Acer TherapeuticsCoLucid PharmaceuticalsAcanthasAurka PharmaCoLucid
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 3
3 acquisitionsAcanthasacq. by Eli LillyAurka Pharmaacq. by LillyCoLucidacq. by Lilly
Public market activity · per SEC filings
what is this? ⓘDisclosed stake · filed Mar 2011
Disclosed stake · filed Feb 2008
10 insider ownership filings (Forms 3/4/5)
From the firm's own SEC EDGAR filings — stakes and insider roles in public companies, typically portfolio companies after an IPO. Not a portfolio list published by the firm.
Frequently asked questions
- How many investments has TVM Capital made?
- TVM Capital has 9 tracked investments, 3 of which have exited.
- What stage does TVM Capital invest at?
- TVM Capital invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is TVM Capital's typical check size?
- TVM Capital typically writes checks of $1.1M – $16.2M.
- What sectors does TVM Capital focus on?
- TVM Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is TVM Capital located?
- TVM Capital is headquartered in Munich, DE.
- Does TVM Capital lead rounds?
- Yes, TVM Capital leads investment rounds.
- Who does TVM Capital co-invest with?
- TVM Capital most often shares deals with Green Park & Golf Ventures, JStar Capital Investments, Pappas Capital, among 4 tracked co-investors.
Media · Podcasts & interviews
featuring the teamBIO-Europe 2025: Interview with Dr. Hubert Birner from TVM Capital Life Science
MC Services AG · Hubert Birner
Bob Wilson, EGG Medical & Luc Marengere, TVM Capital Life Science - Studio Interview | LSI USA ‘24
LSI - Life Science Intelligence™ · Luc Marengere
BIO-Europe Spring 2024: Interview with Hubert Birner from TVM Capital Life Science
MC Services AG · Hubert Birner
BIO-Europe 2023: Interview with Hubert Birner of TVM Capital
MC Services AG · Hubert Birner
Where is the Money Going in Biotech? - Hubert Birner, Managing Partner at TVM Capital
Labiotech.eu · Hubert Birner
Images
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Menlo Ventures is an early-stage venture capital firm backing transformative technology companies, with a strong current emphasis on artificial intelligence across enterprise, healthcare, and consumer markets.
Norwest is a venture capital and growth equity investment firm that has backed over 700 companies across technology, consumer, and healthcare over its 65-year history.
Sofinnova is an investment firm focused on the life sciences and biotechnology sector, partnering with companies from inception through drug development, regulatory approval, company building, and IPO.